Llueca Antoni, Barneo-Muñoz Manuela, Escrig Javier, de Llanos Rosa
Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery (MUAPOS), University General Hospital of Castellon, 12071 Castellón, Spain.
Department of Medicine, University Jaume I (UJI), 12071 Castellon, Spain.
J Pers Med. 2021 Oct 20;11(11):1052. doi: 10.3390/jpm11111052.
Surgical societies of different specialties have lately demonstrated a growing concern regarding the potential risk of SARS-CoV-2 transmission during surgery, mainly via aerosols carrying SARS-CoV-2 particles during laparoscopy smoke evacuation. Since there is not sufficient scientific evidence to rule out this hypothesis, our study aimed to evaluate the prevalence of the appearance of SARS-CoV-2 genetic material in the in-filter membrane of the smoke filter systems, used in laparoscopic surgery, in a tertiary referral hospital during the peak phases of the pandemic.
During the highest incidence of the pandemic outbreak, 180 laparoscopic smoke evacuation systems were collected from laparoscopies performed between April 2020 and May 2021 in University General Hospital of Castellón. As part of the safety protocol established as a result of the pandemic, an oropharyngeal reverse-transcription polymerase chain reaction (RT-PCR) was performed before surgery. We performed RT-qPCR tests for the detection and quantification of SARS-CoV-2 genetic material in the in-filter membranes extracted from the smoke evacuation systems.
We found two RT-qPCR positive in-filters from a sample of 128 patients with SARS-CoV-2-negative results in their oropharyngeal RT-qPCR, i.e., 1.6% (95% CI: 0.5-5.5%). From this estimation, the predictive posterior probabilities of finding cases of negative oropharyngeal COVID-19 patients with positive filters increases with the increasing number of surgeries performed.
This cross-sectional study provides evidence suggesting that airborne transmission of SARS-CoV-2 particles from smoke evacuation of aerosols carrying viral particles during laparoscopy should not be ruled out.
不同专业的外科协会最近对手术期间SARS-CoV-2传播的潜在风险表现出越来越多的关注,主要是通过腹腔镜烟雾抽吸过程中携带SARS-CoV-2颗粒的气溶胶传播。由于没有足够的科学证据排除这一假设,我们的研究旨在评估在大流行高峰期,一家三级转诊医院腹腔镜手术中使用的烟雾过滤系统的进滤膜中出现SARS-CoV-2遗传物质的患病率。
在大流行爆发的最高发病率期间,从2020年4月至2021年5月在卡斯特利翁大学总医院进行的腹腔镜手术中收集了180个腹腔镜烟雾抽吸系统。作为因大流行而制定的安全协议的一部分,在手术前进行了口咽逆转录聚合酶链反应(RT-PCR)。我们对从烟雾抽吸系统中提取的进滤膜进行了RT-qPCR测试,以检测和定量SARS-CoV-2遗传物质。
我们在128例口咽RT-qPCR结果为SARS-CoV-2阴性的患者样本中发现了两个RT-qPCR阳性的进滤膜,即1.6%(95%CI:0.5-5.5%)。根据这一估计,发现口咽COVID-19阴性患者的过滤器呈阳性的病例的预测后验概率随着手术数量的增加而增加。
这项横断面研究提供了证据,表明不应排除在腹腔镜手术期间,携带病毒颗粒的气溶胶的烟雾抽吸导致SARS-CoV-2颗粒通过空气传播。